Fresenius Medical Care AG & Co KGaA
FMEG.DE- Latest Trade
- trading higher38.52EUR
- 1.45
- 3.91%
- As of Mar 27 2023. Values delayed up to 15 minutes
- Today's Range
- 37.41 - 38.65
- 52 Week Range
- 25.95 - 63.66
- Previous Close
- 37.07
- Open
- 37.55
- Volume
- 177,331.00
- 3 Month Average Trading Volume
- 17.14
- Shares Out (Mil)
- 293.41
- Market Cap
- 10,876.84
- Forward P/E
- 15.90
- Dividend Yield
- 3.02
Key Statistics
3.40 mean rating - 20 analysts
- P/E Excl. Extra Items (TTM)
- 16.14
- Price To Sales (TTM)
- 0.56
- Price To Book (Quarterly)
- 0.78
- Price To Cash Flow (Per Share TTM)
- 4.16
- Total Debt/Total Equity (Quarterly)
- 94.45
- Long Term Debt/Equity (Quarterly)
- 79.89
- Return On Investment (TTM)
- 3.33
- Return On Equity (TTM)
- 2.55
2021 (millions USD)
About Fresenius Medical Care AG & Co KGaA (FMEG.DE)
Company Information
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Address
Else-Kroener-Strasse 1BAD HOMBURG VOR DER HOHE,
61352
Germany
Industry
Healthcare Facilities
Executive Leadership
- Dieter Schenk
- Chairman of the Supervisory Board
- Rice Powell
- Chairman of the Management Board, Chief Executive Officer
- Ben J. Lipps
- Honorary Chairman
- Rolf A. Classon
- Independent Vice Chairman of the Supervisory Board
- Helen Giza
- Chief Financial Officer, Member of the Management Board, Chief Transformation Officer
- Frank W. Maddux
- Member of the Management Board, Global Chief Medical Officer
- Katarzyna Mazur-Hofsaess
- Member of the Management Board, Chief Executive Officer - Care Enablement
- William Valle
- Member of the Management Board, Chief Executive Officer - Care Delivery
- Gregory Sorensen
- Independent Member of the Supervisory Board
- Dorothea Wenzel
- Independent Member of the Supervisory Board
- Pascale Witz
- Independent Member of the Supervisory Board
- Gregor Zuend
- Independent Member of the Supervisory Board
Latest News
- MarketsActivist Engine Capital becomes 2nd investor to call for Brenntag break-up
Activist investor Engine Capital took a 1% stake in Germany's Brenntag SE and became the second shareholder to urge the chemicals distributor to spin off its specialties unit, saying this would dramatically boost its shares.
- BusinessFMC boss leaves after two months as Fresenius pushes for changes
German dialysis specialist Fresenius Medical Care's (FMC) Chief Executive Carla Kriwet stepped down on Monday, marking the second leadership change in as many months as parent Fresenius pushes for a faster overhaul of the struggling unit.
Financials
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,982.10 | -- |
| Copper | 786.80 | 0.13% |
| Brent Crude Oil | 76.22 | 1.64% |
| CBOT Soybeans | 1,433.00 | 0.33% |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,970.99 | -- |
| Euro STOXX 50 | 4,171.97 | 1.00% |
| FTSE 100 | 7,484.21 | 1.06% |
| Nikkei 225 | 27,476.87 | 0.33% |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes